CHRS

Coherus BioSciences Stock Price

18.33
0.34 (1.89%)
Upgrade to Real-Time
Afterhours (Closed)
18.33
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Coherus BioSciences Inc CHRS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.34 1.89% 18.33 20:00:00
Open Price Low Price High Price Close Price Prev Close
17.88 17.70 18.38 18.33 17.99
Bid Price Ask Price Spread News
16.50 18.45 1.95 - 1
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,483 545,850 $ 18.08 $ 9,869,520 981,921 10.8616 - 23.03
Last Trade Time Type Quantity Stock Price Currency
19:44:58 50 $ 18.45 USD

Coherus BioSciences Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.32B 72.05M 58.49M $ 356.07M $ 119.39M 1.20 8.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Coherus BioSciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CHRS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week18.0018.5017.6718.00930,9910.331.83%
1 Month17.5018.5016.6817.581,086,6550.834.74%
3 Months17.0719.1216.4417.73909,4541.267.38%
6 Months18.7620.71516.2618.15910,773-0.43-2.29%
1 Year19.2823.0310.861617.681,176,511-0.95-4.93%
3 Years10.8523.918.3216.83945,5687.4868.94%
5 Years14.4131.988.0517.27756,8643.9227.2%

Coherus BioSciences Description

Coherus BioSciences Inc is a United States based biotherapeutics company engaged in developing and commercializing biosimilar therapeutics. The company focuses on process science, analytical characterization, protein production, and clinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates. Geographically, the group has a business presence in the United States and other countries.


Your Recent History
NASDAQ
CHRS
Coherus Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.